Stock 0RAG CERENIS THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Cerenis Therapeutics CINNOBER BOAT

Equities

0RAG

FR0012616852

Delayed CINNOBER BOAT
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cerenis Therapeutics -.--% -.--%
Jun. 14 Abionyx: positive response from FDA, share price rises CF
Jun. 13 ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis CI

Chart calendar Cerenis Therapeutics

4b1a177995d7b1e7983875e2.F__VDepvyvTKfoLmlK2dGG0WZoShV0WK5S9gUPugIUg.fsmKT60toa2sCdK01cPOIABgPMX1Ahfap2RYCZzWa3EnzIZXmCChs5UW0w~5705ca1aa39b4301e65ff920eb77d8f9

Upcoming events on Cerenis Therapeutics

2024-08-21 Q2 2024 Sales and Revenue Release
2024-09-25 Q2 2024 Earnings Release
2024-11-13 Q3 2024 Sales and Revenue Release
2025-03-17 Q4 2024 Earnings Release (Projected)
2025-09-24 Q2 2025 Earnings Release (Projected)
2026-03-16 Q4 2025 Earnings Release (Projected)
2026-09-23 Q2 2026 Earnings Release (Projected)

Past events on Cerenis Therapeutics

2024-05-16 12:00 pm Q1 2024 Sales and Revenue Release
2024-03-11 02:30 am Q4 2023 Earnings Release
2024-02-28 Q4 2023 Sales and Revenue Release
2023-11-15 Q3 2023 Sales and Revenue Release
2023-11-03 10:00 am American Society of Nephrology Kidney Conference - Poster No: FR-PO1818
2023-11-02 04:30 pm American Society of Nephrology Kidney Conference - Poster No: TH-OR080
2023-11-02 10:00 am American Society of Nephrology Kidney Conference - Poster No: TH-PO1158
2023-09-26 02:00 pm Q2 2023 Earnings Release
2023-08-16 Q2 2023 Sales and Revenue Release
2023-05-16 Q1 2023 Sales and Revenue Release
2023-03-29 12:48 pm Q4 2022 Earnings Release
2023-02-28 12:41 pm Q4 2022 Sales and Revenue Release
2022-11-16 Q3 2022 Sales and Revenue Release
2022-09-29 01:39 pm Interim 2022 Earnings Release
2022-08-17 Interim 2022 Sales and Revenue Release
2022-05-19 12:00 pm Q1 2022 Sales and Revenue Release
2022-04-28 12:17 pm FY 2021 Earnings Release
2022-02-24 12:00 pm FY 2021 Sales and Revenue Release
2021-11-03 Q3 2021 Sales and Revenue Release
2021-09-09 12:45 pm Interim 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,70
0,70
0%		5,30
2,65
100%		4,60
4,60
0%
4,60

EBITDA
Million EUR		Released
Forecast
Spread 		-2,51
-5,87
57.19%		-2,95
-7,30
59.64%		-5,83
-3,00
-94.43%		0,00
-5,44
- 		-3,26
-4,00
18.53%
-5,70

EBIT
Million EUR		Released
Forecast
Spread 		-2,50
-5,87
57.39%		-3,00
-7,30
58.9%		-5,95
-3,25
-83.14%		-4,11
-5,74
28.38%		-3,40
-4,60
26.09%
-6,30

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		1,89
-3,60
152.42%		-1,89
-6,60
71.42%		-5,82
-3,30
-76.42%		0,00
-6,04
- 		0,00
0,00
-
0,00

Net income
Million EUR		Released
Forecast
Spread 		1,80
-0,59
402.77%		-1,90
0,00
- 		-5,82
-3,40
-71.24%		-4,21
-5,82
27.76%		-3,50
-4,70
25.53%
-6,50

EPS
EUR		Released
Forecast
Spread 		0,09
-0,19
147.94%		-0,08
-0,35
77.03%		-0,23
-0,14
-66.52%		0,00
-0,22
- 		-0,12
-0,14
14.29%
-0,16

Announcement Date10/03/2025/02/2128/04/2229/03/2311/03/24-

Quarterly results

Fiscal PeriodDecember 2023 S1
Net sales
Million EUR		Released
Forecast
Spread 		2,13


Net income
Million EUR		Released
Forecast
Spread 		-2,25


Announcement Date26/09/23

Upcoming sector events for Cerenis Therapeutics

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Cerenis Therapeutics

2024-06-05 03:51 am PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ABNX Stock
  4. 0RAG Stock
  5. Calendar Cerenis Therapeutics